---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-037254"
form_type: "8-K"
ticker: "VVOS"
cik: "0001716166"
company_name: "Vivos Therapeutics, Inc."
filed_at: "2024-09-20T23:59:59+00:00"
generated_at: "2026-05-31T02:49:06.620860+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Vivos Therapeutics prices $4.3M registered direct offering of 1,363,812 shares at $3.15/share

## Summary
- Gross proceeds of ~$4.3M before fees; closing expected Sept 20, 2024.
- Placement agent H.C. Wainwright receives 7% cash fee plus 95,467 warrants at $3.9375.
- Net proceeds to be used for working capital and general corporate purposes.
- No warrants issued to investors; offering priced at-the-market under Nasdaq rules.
- Shares sold under effective shelf registration statement (File No. 333-262554).

## SEC filing metadata
- accession: 0001493152-24-037254
- form_type: 8-K
- ticker: VVOS
- cik: 0001716166
- company_name: Vivos Therapeutics, Inc.
- filed_at: 2024-09-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716166/000149315224037254/0001493152-24-037254-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716166/000149315224037254/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-037254
- JSON: https://secwatch.observer/filing/0001493152-24-037254.json
- Plain text: https://secwatch.observer/filing/0001493152-24-037254.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.